
For clinics and hospitals
Add an evidence-based, non-invasive option to your myopia management service.
- Demo device and hands-on training
- Simple prescribing workflow with IHCC
- Online monitoring of every patient session
- Local support in Saudi Arabia
The Eyerising Myopia Management Device delivers repeated low-level red-light (RLRL) therapy at home, in three-minute sessions prescribed and monitored by your eye-care professional.
In most children, myopia gets worse because the eyeball grows too long from front to back. About 1 mm of extra growth adds roughly 2.5 to 3.0 diopters to the prescription. Glasses make vision clear, but they do not slow that growth.


Axial length +1 mm ≈ 2.5–3.0 D
The child looks into the device while it delivers low-level red light (650 nm) to the back of the eye. Studies link this to a thicker choroid and slower axial elongation. The device records every session, so the clinician can follow compliance and progress.




Add an evidence-based, non-invasive option to your myopia management service.

Understand your child’s myopia, the treatment options, and what RLRL therapy at home involves.
Multiple randomised clinical trials and systematic reviews report slower eye growth with RLRL compared with single-vision spectacles alone.
Long-term safety beyond several years, the ideal dose and what happens after stopping are still being studied. That is why treatment is supervised.
less axial elongation over 1 to 2 years, compared with controls
Meta-analyses, 2023–2026less myopic shift in prescription over 1 to 2 years
Meta-analyses, 2023–2026slower myopia progression reported in some trials, as cited by the manufacturer
Jiang et al., Ophthalmology 2022The on-screen guide, Willow, walks children through each session. Watch how a family sets up and uses the device at home.


The eye-care professional measures axial length, refraction and choroidal thickness (biometry and OCT).
If RLRL is suitable, the clinic prescribes a 3, 6 or 12 month treatment through IHCC.
The family receives the device with set-up, training and a user guide.
Reviews at 1 month, 3 months, then every 6 months, with session data shared online.

Myopia, or short-sightedness, is a focusing error. Near objects look clear, but distant ones such as the school board or road signs look blurry. In most cases the eyeball is longer than normal, so light focuses in front of the retina.
Usually because the eye is growing too long from front to back. About 1 mm of extra axial length adds roughly 2.5 to 3.0 diopters. Treatment aims to slow that growth, not only to change the glasses number.
A non-invasive treatment where the child looks into a desktop device that delivers gentle red light, around 650 nm, for 3 minutes, usually twice a day, under professional supervision. Studies report significantly slower axial elongation compared with standard spectacles alone.
Clinical trials have reported no severe adverse events, and supervision is built into the treatment. Long-term safety beyond several years, the ideal dose and the effect after stopping are still being studied, so it must be prescribed and monitored by an eye-care professional.
Excessive screen time is associated with a higher risk, especially with long near work and little outdoor time. Reduce unnecessary screen use, take breaks, play outdoors and avoid holding devices very close.
Talk to IHCC about partnership, training and a demo device.